Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

 

Exjade (deferasirox) Tablets - Important Safety Information from Novartis as approved by the Irish Medicines Board

23 May 2007

Tags: Human medicinesHealthcare professionalsDirect Healthcare Professional Communication2007

Please find attached Safety Communication from Novartis in respect of Exjade (deferasirox) 125mg, 250mg and 500mg dispersible tablets


« View Publications List



Date Printed: 19 June 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971